Circulating anti-insulin receptor antibodies in a patient suffering from lupus nephritis and hypoinsulinemic hypoglycaemia
- PMID: 6663610
Circulating anti-insulin receptor antibodies in a patient suffering from lupus nephritis and hypoinsulinemic hypoglycaemia
Abstract
A 46-year-old female patient suffering from Lupus Nephritis came to our attention in 1981 for severe recurrent hypoglycaemia; she was obliged to eat every 5-7 hr to maintain glucose values not below 1.3-1.6 mM. All known causes of hypoglycaemia were excluded by performing selective angiography of the pancreas and skull, chest and abdominal computerized tomography, as well as stimulation and suppression tests. Oral glucose tolerance, tolbutamide and intravenous insulin (0.4 U/Kg b.w.) tests demonstrated that the patient was highly insulin resistant; furthermore, studies on the patient's red blood cells suggested that her insulin receptors were completely unable to bind insulin. Studies carried out to reveal the reason for this binding inhibition demonstrated that red blood cells from normal subjects as well as adipocytes from normal rats incubated with the patient's serum did not bind insulin (50% inhibition occurring at about 1:30 serum dilution). Insulin binding inhibitors were found in the fraction of the serum precipitated by ammonium sulphate. The serum cleared of IgG fraction was unable to affect insulin binding. These data demonstrate that the serum from the female patient investigated contained anti-insulin receptor antibodies blocking the binding of insulin to its receptors. Plasmapheresis improved the patient's metabolic status. The clinical picture would suggest that recurrent hypoglycaemia was caused by anti-insulin receptor antibodies acting as insulin on target cells.
Similar articles
-
Systemic lupus erythematosus presenting as hypoglycaemia with insulin receptor antibodies and insulin autoantibodies.Lupus. 2009 Apr;18(5):457-9. doi: 10.1177/0961203308098188. Lupus. 2009. PMID: 19318401
-
Spontaneous hypoglycaemia in the presence of both anti-insulin antibody and anti-insulin receptor antibody.Diabetes Metab. 2006 Dec;32(6):598-603. doi: 10.1016/S1262-3636(07)70314-2. Diabetes Metab. 2006. PMID: 17296513
-
Hypoglycemia due to antiinsulin receptor antibodies in systemic lupus erythematosus.J Rheumatol. 1990 Sep;17(9):1226-9. J Rheumatol. 1990. PMID: 2290167
-
Autoantibodies to the insulin receptor as a cause of autoimmune hypoglycemia in systemic lupus erythematosus.Am J Med. 1988 Feb;84(2):334-8. doi: 10.1016/0002-9343(88)90436-6. Am J Med. 1988. PMID: 3044073 Review.
-
Syndromes of autoimmunity and hypoglycemia. Autoantibodies directed against insulin and its receptor.Endocrinol Metab Clin North Am. 1989 Mar;18(1):123-43. Endocrinol Metab Clin North Am. 1989. PMID: 2645123 Review.
Cited by
-
Development of a novel diagnostic assay for insulin receptor autoantibodies based on a patient with autoimmune hypoglycaemia.Front Endocrinol (Lausanne). 2022 Oct 25;13:1029297. doi: 10.3389/fendo.2022.1029297. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36387920 Free PMC article.
-
PTEN Deletion in Adult Mice Induces Hypoinsulinemia With Concomitant Low Glucose Levels.Front Endocrinol (Lausanne). 2022 Feb 25;13:850214. doi: 10.3389/fendo.2022.850214. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35282439 Free PMC article.
-
Clinical evaluation of insulin resistance and beta-cell function by the homeostasis model assessment in patients with systemic lupus erythematosus.Clin Rheumatol. 2004 Oct;23(5):416-20. doi: 10.1007/s10067-004-0908-5. Epub 2004 May 18. Clin Rheumatol. 2004. PMID: 15459813
-
Systemic lupus erythematosus presenting as hypoglycemia with insulin receptor antibodies.West J Med. 1989 Sep;151(3):324-5. West J Med. 1989. PMID: 2588569 Free PMC article. No abstract available.
-
Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action.J Endocrinol Invest. 1990 Dec;13(11):951-68. doi: 10.1007/BF03349669. J Endocrinol Invest. 1990. PMID: 2090677 Review. No abstract available.